JAN 27, 2021 3:30 PM PST

Researchers Discover How LSD Encourages Prosocial Behavior

WRITTEN BY: Annie Lennon

Researchers from McGill University have discovered one of the possible mechanisms by which lysergic acid diethylamide (LSD) increases social behaviors. Their findings may go on to inform ways to treat certain psychiatric illnesses, including anxiety and alcohol use disorders. 

For the study, the researchers gave mice low doses of LSD over a period of seven days, during which they noticed an increase in their sociability. To understand how this happened, they used optogenetics, an imaging technique in which genes for light-sensitive proteins are introduced to certain types of brain cells so they can be monitored and controlled with light signals. 

In the end, the researchers found that increased sociability came from a cascade of events beginning with the activation of the serotonin 5-HT2A receptors in the prefrontal cortex. This then went on to activate the excitatory synapses of AMPA receptors (glutamate receptors) in the same area, as well as a cellular protein known as mTORC 1, which is known to be dysregulated in conditions displaying social deficits such as in autism spectrum disorder. 

To ascertain their findings, once these pathways had been mapped, the researchers used optogenetics to deactivate the prefrontal cortex area and see how prosocial behavior was affected. As predicted, when excitatory transmissions in the prefrontal cortex were deactivated, LSD did not have the same prosocial effects. 

The researchers now hope to investigate how LSD may be used to treat mice displaying behavioral deficits similar to humans with autism spectrum and social anxiety disorders. They ultimately hope to explore whether microdoses of LSD or other similar compounds may have a similar effect on humans, and whether it could be used as a therapeutic. 

“Social interaction is a fundamental characteristic of human behaviour,” says Dr. Gabriella Gobbi, co-lead author of the paper “These hallucinogenic compounds, which, at low doses, are able to increase sociability may help to better understand the pharmacology and neurobiology of social behavior and, ultimately, to develop and discover novel and safer drugs for mental disorders.”

 

Sources: Neuroscience NewsPNAS

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
AUG 01, 2021
Drug Discovery & Development
Berry Compound Reverses Parkinson's in Mice
AUG 01, 2021
Berry Compound Reverses Parkinson's in Mice
A naturally-occurring compound called farnesol found in berries and other fruits prevents and reverses Parkinson's-a ...
AUG 13, 2021
Cancer
Ultrasound Triggers Immunotherapy to Destroy Tumors
AUG 13, 2021
Ultrasound Triggers Immunotherapy to Destroy Tumors
An immunotherapy engineered to be triggered by ultrasound beams significantly slows the growth of cancerous tumors in mi ...
AUG 24, 2021
Drug Discovery & Development
A comparison of drugs for relapsing-remitting multiple sclerosis.
AUG 24, 2021
A comparison of drugs for relapsing-remitting multiple sclerosis.
     Multiple sclerosis (MS) is a rare and unpredictable autoimmune disease in which the body’s inn ...
SEP 09, 2021
Health & Medicine
Cannabis and Pain Management- A Double Edged Sword?
SEP 09, 2021
Cannabis and Pain Management- A Double Edged Sword?
In 2016 it was estimated by the CDC that 20.4% of Americans have chronic pain. Chronic pain is a primary reaso ...
SEP 22, 2021
Cancer
Whole Genome Sequencing for Cancer Diagnostics
SEP 22, 2021
Whole Genome Sequencing for Cancer Diagnostics
The human genome consists of genetic material known as DNA.  We all have unique DNA sequences made up of four bases ...
OCT 15, 2021
Drug Discovery & Development
Oxytocin Therapy Shows No Benefit for Autistic Children
OCT 15, 2021
Oxytocin Therapy Shows No Benefit for Autistic Children
Intranasal oxytocin therapy does not benefit autistic children and adolescents. The corresponding study was published in ...
Loading Comments...